A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build

Simply Wall St.05-29

AdvertisementAI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2639241620?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","is_english":true,"pubTime":"2026-05-29 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639241620","market":"sg","top_or_hot":-1,"title":"A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementAI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/a-look-at-cellebrite-di-nasdaqgsclbt-valuation-as-ai-and-fed\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-29 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/a-look-at-cellebrite-di-nasdaqgsclbt-valuation-as-ai-and-fed><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementAI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/a-look-at-cellebrite-di-nasdaqgsclbt-valuation-as-ai-and-fed\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/a-look-at-cellebrite-di-nasdaqgsclbt-valuation-as-ai-and-fed","article_id":"2639241620","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/a-look-at-cellebrite-di-nasdaqgsclbt-valuation-as-ai-and-fed","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2639241620","pubTimestamp":1780056659,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"AI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus\nFresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation tools, plus FedRAMP authorization for its cloud platform, have put the stock back onto investor watchlists.\nProject Genesis, the company’s new AI tool aimed at cutting investigation times, is seeing early customer interest, and recent updates highlight growth in annual recurring revenue along with a thicker...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","AGIX":"通用人工智能 ETF-AGIX","BGSX":"Build Acquisition Corp","BK4543":"AI","AIYY":"YIELDMAX AI OPTION INCOME STRATEGY ETF","CLBT":"Cellebrite","AIPO":"Defiance AI and Power Infrastructure ETF","BK4551":"寇图资本持仓","BK4613":"AI应用软件","AI":"C3.ai, Inc.","BK4587":"ChatGPT概念","ARTY":"ISHARES FUTURE AI & TECH ETF","BK4528":"SaaS概念","BK4588":"碎股","BK4023":"应用软件","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF"},"translate_title":"随着人工智能和FedRAMP云势头的增强，看看Cellebrite DI（纳斯达克GS：CLBT）的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLBT":1.5,"AI":0.8,"AGIX":1.5,"AIPO":1.5,"BGSX":1.5,"AIYY":0.6,"CHAT":1.5,"ARTY":1.5},"content_text":"AdvertisementAI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation tools, plus FedRAMP authorization for its cloud platform, have put the stock back onto investor watchlists. Project Genesis, the company’s new AI tool aimed at cutting investigation times, is seeing early customer interest, and recent updates highlight growth in annual recurring revenue along with a thicker U.S. federal pipeline. See our latest analysis for Cellebrite DI. Despite the recent headlines around AI tools and FedRAMP authorization, Cellebrite DI’s share price at US$13.20 still reflects pressure, with the year to date share price return down 26.01% even as the 3 year total shareholder return is up a little over 2x. If you are looking beyond a single stock and want to see what else is moving in AI, this could be a useful moment to scan 64 profitable AI stocks that aren't just burning cash So with Cellebrite’s shares down year to date, yet trading at what looks like a discount to analyst targets and some estimates of intrinsic value, is this weakness a chance to buy, or is the market already pricing in future growth? Most Popular Narrative: 39.1% Undervalued With Cellebrite DI last closing at $13.20 versus a most followed fair value estimate of $21.67, the current price sits well below that narrative view of worth.  The continued transition to a recurring, subscription-based revenue model, with over 90% of revenues now from subscriptions and growing SaaS/cloud penetration, improves revenue visibility, predictability, and operating leverage. This is already translating into higher EBITDA and free cash flow margins and is likely underappreciated in current valuations.  Read the complete narrative. Curious what revenue mix, margin path, and future profit multiple have to line up to reach that fair value gap? The full narrative spells out the earnings runway, the pricing power assumptions, and the kind of premium P/E that would need to hold for that valuation to stick. Result: Fair Value of $21.67 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this story can change quickly if delays in U.S. federal contracts persist, or if tighter privacy rules restrict how agencies use Cellebrite’s tools. Find out about the key risks to this Cellebrite DI narrative. Another View: Market Multiple Sends A Different Signal So far the story points to Cellebrite DI looking undervalued against fair value estimates and analyst targets. The P/E ratio tells a more complicated story, with the stock trading at 46.1x earnings, above the US Software industry at 29.2x and also above a fair ratio of 29.7x, even though it sits below a 69.4x peer average. That mix of rich and cheap readings can either flag valuation risk if growth wobbles or potential upside if the higher earnings outlook plays out. Which side of that tradeoff do you think deserves more weight? See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:CLBT P/E Ratio as at May 2026Next Steps If the mix of optimism and caution in this article leaves you on the fence, it is worth checking the data now and deciding where you stand. To weigh those positives in context, review the 3 key rewards Looking for more investment ideas? If Cellebrite DI has caught your attention, do not stop there. Use this moment to broaden your watchlist with stocks that fit your own risk and income preferences.  Target potential mispricing by scanning companies flagged as high quality but currently out of favor with the 46 high quality undervalued stocks Strengthen your defensive side by reviewing resilient businesses with sturdy finances through the solid balance sheet and fundamentals stocks screener (46 results) Get ahead of the crowd by spotting lesser known opportunities using the screener containing 22 high quality undiscovered gems   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639241620","isCrawlerRequest":true}